Paclitaxel protein-bound particles

Product NDC
69097-398
11-digit product format
690970398
Labeler code
69097
Product ID
69097-398_7dcacda6-4a5c-4840-8f8d-cbf7b30f3415
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Paclitaxel protein-bound particles
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Labeler
Cipla USA Inc.
Application
ANDA209657
Marketing category
ANDA
Marketing start
2025-04-15
Substance
PACLITAXEL
Active strength
100 mg/20mL
Pharmacologic classes
Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A209657-001PACLITAXELPACLITAXEL100MG/VIALPOWDER / INTRAVENOUSAB2025-04-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A209657-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A209657-001PACLITAXEL100MG/VIALPOWDER / INTRAVENOUSAB2025-04-10011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209657-001PACLITAXEL100MG/VIALPOWDER / INTRAVENOUSAB2025-04-1031067a03dcf5…
2025-08-23 18:47 UTC2025-08A209657-001PACLITAXEL100MG/VIALPOWDER / INTRAVENOUSAB2025-04-106a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A209657-001PACLITAXEL100MG/VIALPOWDER / INTRAVENOUSAB2025-04-10a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A209657-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209657-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A209657-001AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A209657-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Paclitaxel protein-bound particles
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PACLITAXEL100 mg/20mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
P88XT4IS4DInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
583214Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
15eba86c-d9de-42e6-bc95-70ba4c015e72Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9bfd8626-d4ce-43ae-acb3-8de37f80302fProduct name320260126
2cc1dc98-28db-3a82-b37e-4e50de7c4f94Product name520240102
a05831c4-07a7-44ad-9dc5-89391450ee82Product name120230323

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69097-398-78Paclitaxel protein-bound particles20 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,202
69097-398-78Paclitaxel protein-bound particles1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69097-398-78EA - Each69097-398a13b7adf-9846-458f-9471-3d6d5577d62012025-07-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69097-398PACLITAXEL PROTEIN-BOUND PARTICLES INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [CIPLA USA INC.]2Current NDC, 2 package rows20250417_15eba86c-d9de-42e6-bc95-70ba4c015e72.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Paclitaxel protein-bound particlesPACLITAXEL PROTEIN-BOUND PARTICLESCipla USA Inc.15eba86c-d9de-42e6-bc95-70ba4c015e722025-04-02Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209657
application number: ANDA209657
ndc (product): 69097-398

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
583214PACLitaxel 100 MG InjectionPSN15eba86c-d9de-42e6-bc95-70ba4c015e722
583214paclitaxel 100 MG InjectionSCD15eba86c-d9de-42e6-bc95-70ba4c015e722

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
69097-398-78690970398781 VIAL, SINGLE-DOSE in 1 CARTON (69097-398-78) / 20 mL in 1 VIAL, SINGLE-DOSE2025-04-15NoNoCurrent